LCN2 and exocrine pancreatic carcinoma: Although LCN2 reportedly inhibits the late-stage progression of angiogenesis and EMT in pancreatic carcinoma and ovarian carcinoma, respectively, a high LCN2 level in the early stage implies a role for LCN2 in tumorigenesis.